ESC 365 - All diabetic patients should be treated with SGLT2 inhibitors.

ESC Professional Premium Access

All diabetic patients should be treated with SGLT2 inhibitors.

Session: Meet the Experts: how to lower cardiovascular disease risk in patients with diabetes

Topic: Cardiovascular Pharmacotherapy

Speaker: Associate Professor L. Mellbin (Stockholm, SE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Associate Professor Linda Mellbin

Karolinska University Hospital, Stockholm (Sweden)

7 presentations

0 follower

4 more presentations in this session

Assessment of risk in diabetic patients.

Speaker: Professor F. Cosentino (Stockholm, SE)

All diabetic patients should be treated with GLP1 and/or GIP agonists.

Speaker: Professor A. Cahn (Jerusalem, IL)

All diabetic patients should be treated with metformin.

Speaker: Professor H. Drexel (Feldkirch, AT)

Putting it all together: how to lower cardiovascular disease risk in patients with diabetes.

Speaker: Professor N. Marx (Aachen, DE)

Access the full session

Meet the Experts: how to lower cardiovascular disease risk in patients with diabetes

Speakers: Associate Professor L. Mellbin, Professor F. Cosentino, Professor A. Cahn, Professor H. Drexel, Professor N. Marx

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources